期刊文献+

p33^(INGI)、p53在结直肠癌中的表达及其相互关系

Expression of p33^(ING1) and p53 in colorectal carcinoma and their relationship between each other
下载PDF
导出
摘要 目的:探讨p33ING1、p53在结直肠癌中的表达及其相互关系。方法:应用免疫组化SP法检测60例结直肠癌组织及相应正常黏膜组织中p33ING1、p53的表达。结果:结直肠癌组织、相应正常黏膜组织中p33ING1蛋白的阳性表达率分别为43.3%(26/60)、100%(60/60)(P<0.01),p53蛋白分别为51.6%(31/60)、0%(0/60)。p33ING1在无淋巴结转移组及淋巴结转移组癌组织中的阳性表达率分别为57.6%(19/33)、25.9%(7/27)(P<0.05);在Dukes A、B期、Dukes C、D期病例中分别为56.7%(17/30)、30.0%(9/30)(P<0.05)。在p53表达阴性的29例中有12例(41.4%,12/29)p33ING1表达缺失,而p53阳性的31例病例中有22例(71.0%,22/31)p33ING1表达阴性(P<0.05),在p53蛋白表达阳性的病例中p33ING1蛋白表达明显缺失,两者表达呈负相关。结论:p33ING1在结直肠癌组织中低表达,与p53互相协同,在结直肠癌的发生、发展中可能起重要作用。 Objective: To investigate the expressions of p33^ING1 and p53 and their relationship in colorectal carcinoma (CRC). Methods: The expressions of p33^ING1 and p53 protein were examined in 60 cases of colorectal cancerous tissue and their corresponding normal mucous tissues by immunohistochemical SP method. Results: The positive expression rates of p33^ING1 were 43.3%(26/60) and 100% (60/60) in CRC and normal mucous tissues, respectively. The positive expression rates of p53 protein were 51.6% (31/60) and 0% (0/60) in CRC and normal mucous tissues, respectively. The positive rates of p33^ING1 expression were 57.6% (19/33) and 25.9% (7/27) in cancerous tissues with or without lymph node metastasis (P〈0.05). The positive rates of p33^ING1 expression in cancerous tissues at Dukes' A and B stages were significantly higher than that at Dukes' C and D stages [56.7% (17/30)vs 30.0% (9/30)]. The expression of p33^ING1 expression was negative in 12 out of 29 p53-negative patients (41.4%). The negative rate was increased to 71.0% (22/31) in p53-positive patients. Conclusion: Low expression of p33^ING1 synergied with p53 may play an important role in the carcinogenesis and development of CRC.
出处 《肿瘤》 CAS CSCD 北大核心 2006年第10期924-926,共3页 Tumor
基金 广西科学基金项目(编号:桂科回0342018) 教育部留学回国启动基金(编号:教外司留2004-176)
关键词 结肠直肠肿瘤 基因 ING1 P53蛋白 免疫组织化学 Colorectal neoplasms genes,ING1 p53 protein Immunohistochemistry
  • 相关文献

参考文献3

二级参考文献21

  • 1Guan-ZhenYu Ming-HuaZhu ZhiZhu Can-RongNi Jian-MingZheng Fang-MeiLi.Genetic alterations and reduced expression of tumor suppressor p33^(ING1b) in human exocrine pancreatic carcinoma[J].World Journal of Gastroenterology,2004,10(24):3597-3601. 被引量:5
  • 2Garkavtsev I, Kazarov A, Gudkov A, et al. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation [J]. Nat Genet, 1996, 14(4) :415-420.
  • 3Bassam B J, Caetano-Anolles G, Gresshoff PM. Fast and sensitive silver straining of DNA in polyacrylamide gels [J].Anal Biochem, 1991,196( 1 ) : 80-83.
  • 4Garkavtsev I, Demetrick D, Riabowol K. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1) [J]. Cytogenet Cell Genet, 1997,76(3): 176-178.
  • 5Zeremski M, Horrigan SK, Grigorian IA, et al. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34 [J]. Somat Cell Mol Genet, 1997,23(3):233-236.
  • 6Gunduz M, Ouchida M, Fukushima K, at el. Genomic structure of the human ING1 gene and tumor-specific mutation detected in head and neck squamous cell carcinomas [J].Cancer Res, 2000,60(12) :3143-3146.
  • 7Garkavtsev I, Riabowol K. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor [J]. Mol Cell Biol, 1997,17(4):2014-2019.
  • 8Helbing CC, Veillette C, Riabowol K, et al. A novel candidate tumor suppression. P33/ING1, is involved in the regulation of apoptosis [J]. Cancer Res, 1997,57(7) : 1255-1258.
  • 9Toyama T, Iwase H, Watson P, et al. Suppression of ING1 expression in sporadic breast cancer [J]. Oncogene, 1999,18(37) :5187-5193.
  • 10Lisheng C, nagahide M, Tadashi Y, et al. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer [J]. Cancer Res, 2001,61 ( 11 ) :4345-4349.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部